Lotus Pharmaceuticals Inc (LTUS.OB)

Not featured in screeners

Not featured in screeners

Ticker: LTUS.OB

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Download results Settings

Jin Liu

1 sale — total 4,750 USD

Sale 28 Jun 2010

Value US$3,894,609.84 | Price 308.19 | Shares 40,149

ROTHBERG MELVIN

1 sale — total 30,444 USD

Sale 2 Jan 2008

Value US$4,210,766.17 | Price 315.14 | Shares 69,015

GENESIS TECHNOLOGY GROUP INC

1 sale — total 374,000 USD

Sale 6 Aug 2007

Value US$374,000.00 | Price 0.55 | Shares 680,000

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2010-07-01	2010-06-28	S Sale	Jin Liu Non-Executive Director	40,149 +42.8% 308.19 US$3,894,610	40,149 +42.8%	308.19	US$3,894,610
2008-01-09	2008-01-02	S Sale	ROTHBERG MELVIN Non-Executive Director	69,015 +17.4% 315.14 US$4,210,766	69,015 +17.4%	315.14	US$4,210,766
2007-08-09	2007-08-06	S Sale	GENESIS TECHNOLOGY GROUP INC Large shareholder	27,351 -6.4% 461.20 US$3,882,660	27,351 -6.4%	461.20	US$3,882,660

More insider trading research around Lotus Pharmaceuticals Inc